Integrated Diabetes Services

/Integrated Diabetes Services

About Integrated Diabetes Services

Integrated Diabetes Services is the worldwide leader in one-on-one consulting for people who use insulin. Diabetes “coaching” services are available in-person and remotely via phone and the internet for children and adults.

Sneak Preview of New Type 1 Diabetes Research to be Presented at EASD Meeting

By | 2017-08-18T14:59:55+00:00 August 16th, 2017|August 2017 Newsletter, Diabetes Bites|

The European Association for the Study of Diabetes 2017 annual meeting will take place in Lisbon, Portugal from September 11-15, 2017. Some interesting research on Type 1 diabetes is on tap for the meeting, so here's a sneak preview!

Type 1 Diabetes Post Meal Insulin Dosing Leads to Poorer Glucose Control

By | 2017-08-18T15:01:22+00:00 August 16th, 2017|August 2017 Newsletter, Diabetes Bites|

Do you tend to bolus for your meal or snack during or after eating? If so, you may be unwittingly getting in your own way.

New Benefits Found With Liraglutide Use in Type 1 Diabetes Patients

By | 2017-08-18T15:01:53+00:00 August 16th, 2017|August 2017 Newsletter, Diabetes Bites|

Although it didn't work wonders for blood glucose (BG) levels, liraglutide improved anthropometric and metabolic parameters without causing an increase in hypoglycemia, according to the results of a clinical trial published in July in Diabetes, Obesity, and Metabolism.

Glucose Concentrations and A1c Levels Vary by Race

By | 2017-08-18T15:02:34+00:00 August 16th, 2017|August 2017 Newsletter, Diabetes Bites|

Have you ever noticed when you look at your lab results, there's a measure of kidney function called eGFR that is reported for both non-African American, and for African American? That's because there are racial and ethnic differences in kidney function decline. When it comes to A1c levels, they are higher in black people than in white people. It is debatable if this is because of poorer glycemic control, or whether there are, in fact, differences between the races in the glycation of hemoglobin.

Encouraging News About Sotagliflozin Use in Type 1 Diabetes

By | 2017-08-18T15:03:20+00:00 August 16th, 2017|August 2017 Newsletter, Diabetes Bites|

Sotagliflozin is a drug in development, under investigation by Lexicon Pharmaceuticals and Sanofi. It is a first-in-class, oral dual inhibitor of sodium-glucose cotransporter types 1 and 2 (SGLT1 and SGLT2).

ViaCyte Starts Clinical Trial on PEC-Direct Islet Cell Replacement Therapy

By | 2017-08-18T15:04:35+00:00 August 15th, 2017|August 2017 Newsletter, Diabetes Bites|

Wouldn't it be great if a commercially-available product existed that was derived from stem cells and could effectively replace pancreatic islet cells to allow folks who can't produce endogenous insulin to actually start making it? ViaCyte is working on turning this into a reality someday.

Nasal glucagon: a viable option

By | 2017-07-14T19:21:02+00:00 July 14th, 2017|July 2017 Newsletter|

According to research presented at the annual meeting of the American Diabetes Association (ADA) in June, a new glucagon product is much easier to use than is the traditional formulation for injection. Could this mean that it's more likely that a caregiver would be willing to administer it when needed?

Taking stock prior to driving reduces risk for drivers with Type 1

By | 2017-07-14T19:58:20+00:00 July 14th, 2017|July 2017 Newsletter|

Drivers with Type 1 diabetes have a higher risk of motor vehicle collisions, as compared to their spouses without diabetes. Are you doing all you can to be a safe driver?